🌐 ItalianoEnglish中文
Full tender Source status · 2 documents · Completeness: 50%

TENDER ANALYSIS No. ASST Garda 2021 - Service ACT (Delibera 129 del 17/02/2022)

Document generated on 04/06/26 12:50

TENDER IDENTIFICATION DATA

TENDER SUBJECT"In-service" supply of automatic analytical systems for the determination of activated clotting time (ACT), for a duration of 72 months, with an early withdrawal clause in case of activation of an ARIA Framework Agreement and an option to renew for a further 12 months.Source: Aggiudicazione.pdf: pagina 1
CONTRACTING AUTHORITYAzienda Socio-Sanitaria Territoriale (ASST) del Garda - Registered office: Desenzano del Garda (BS), Località Montecroce.Source: Avviso-di-avvio-procedura-3.pdf: pagina 1
CIG (tender ID)Not stated in the available documents (notice + award resolution).
PROCEDURE TYPEBelow-threshold award pursuant to art. 1, paras. 1 and 2 lett. a) of Decree-Law 76/2020 (conv. Law 120/2020), via a Request for Quotation (RFQ/RDO) on the Sintel platform (procedure ID 149024566).Source: Aggiudicazione.pdf: pagina 2
PLATFORMSintel of the Lombardy Region / ARIA S.p.A. (www.ariaspa.it, Bandi di gara section on Sintel).Source: Aggiudicazione.pdf: pagina 2
PLACE OF PERFORMANCELaboratories of ASST del Garda: facilities in Desenzano, Manerbio and Gavardo.Source: Aggiudicazione.pdf: pagina 7
AWARD CRITERIONJoint assessment of the fairness of the price and the quality of the product offered, with reference to the technical specifications of the Technical Specifications (Capitolato Tecnico).Source: Aggiudicazione.pdf: pagina 2
BID SUBMISSION DEADLINE16:00 on 12/01/2022.Source: Aggiudicazione.pdf: pagina 3
TOTAL AMOUNTEstimated tender base below € 139.000 (VAT excluded) for 72 months. Awarded amount: € 91.152,00 (VAT excluded) - equal to € 111.205,44 including 22% VAT.Source: Aggiudicazione.pdf: pagina 2
PNRR (recovery funds)Not stated.
OUTCOME / AWARDEEAwarded to Instrumentation Laboratory S.p.A. (Werfen group), the only bid received. Award effective after verification of requirements.Source: Aggiudicazione.pdf: pagina 3

PARTICIPATION REQUIREMENTS

ELIGIBILITY REQUIREMENTSAbsence of the grounds for exclusion under art. 80 of Legislative Decree 50/2016 and possession of the professional suitability requirement under art. 83, paragraph 1, lett. a) of Legislative Decree 50/2016. Prior qualification for ASST del Garda in the relevant product category on Sintel is required.Source: Avviso-di-avvio-procedura-3.pdf: pagina 1
ECONOMIC CAPACITYNot stated.
TECHNICAL CAPACITYNot stated.
SOA CATEGORYNot stated.
CREDIT LICENCENot stated.
ADDITIONAL REQUIREMENTSNot stated
WHITE LISTNot stated.

PRELIMINARY OBLIGATIONS

BID BONDNot stated.
ANAC FEENot stated.
SITE INSPECTIONNot stated.
SAMPLINGNot stated.
TIMESTAMP / DIGITAL SIGNATURENot stated
TECHNICAL OFFERRequired: the bid is assessed against the characteristics of the Technical Specifications (Capitolato Tecnico) (product quality).Source: Avviso-di-avvio-procedura-3.pdf: pagina 1
STAMP DUTYNot stated
LABOUR CONTRACT (CCNL)Not stated
ACCELERATION BONUSNot stated
SUBCONTRACTINGNot stated.
RELIANCE (avvalimento)Not stated.
RTI / CONSORTIUMNot stated
CLARIFICATIONS DEADLINENot stated
FVOE (virtual file)Not stated
CONTRACT DURATION72 months (from 01/04/2022 to 31/03/2028) with an option to renew for a further 12 months and an early withdrawal clause upon activation of an ARIA Framework Agreement.Source: Aggiudicazione.pdf: pagina 1
BID VALIDITY180 days from the deadline set on the Sintel platform.Source: Aggiudicazione.pdf: pagina 7

Custom questions

Is the tender still open?
No: this is a procedure that has already been awarded (Resolution No. 129 of 17/02/2022) to Instrumentation Laboratory S.p.A. The document is useful as a benchmark, not as an open opportunity. Source: Aggiudicazione.pdf: pagina 1
How many bids were received?
Only one bid, from the company Instrumentation Laboratory S.p.A. (Werfen). Source: Aggiudicazione.pdf: pagina 3

TECHNICAL ANALYSIS

Subject: In-service supply of automatic analytical systems for the determination of activated clotting time (ACT).Total base amount: Tender base < € 139.000 (VAT excl.) for 72 months; awarded € 91.152,00 (VAT excl.).No. of lots: 1

LOT 1 — In-service system for activated clotting time (ACT) - POCT

CIGNot stated.
Description / what it isIn-service supply (instrument rental + consumables + full-risk maintenance) of automatic analytical systems for the determination of activated clotting time (ACT) at the laboratories of ASST del Garda.
System / instrumentationAwarded instrument: Hemochron Signature Elite (Instrumentation Laboratory / Werfen). Distribution: 2 instruments at Desenzano, 2 at Manerbio, 1 at Gavardo (5 instruments total) on rental with full-risk technical support.
Base amountEstimate < € 139.000 VAT excl. (72 months). Awarded: consumables € 55.152,00 + equipment rental and full-risk support € 36.000,00 = € 91.152,00 (six-year, VAT excl.).
Volumes1.800 ACT determinations per year.
Duration72 months (01/04/2022 - 31/03/2028) + 12-month option.
Required tests
  • ACT-LR (Low Range) test - cartridges including everything needed to run the controls
  • Quality Control abnormal ACT-LR (pack of 15 pcs.)
  • Quality Control normal ACT-LR (pack of 15 pcs.)
Technical requirements
  • Automatic analytical systems for ACT determination
  • In-service supply: instrument rental + full-risk technical support included
  • Quality controls (normal and abnormal) included in the supply
  • No minimum order
SamplingNot stated.
NotesUseful economic benchmark: cost per single determination € 5,11; rental + full-risk support fee € 1.200,00/instrument/year. Historical awardee: Instrumentation Laboratory (Werfen) with Hemochron Signature Elite.
Sources
  • Aggiudicazione.pdf: pagina 3
  • Aggiudicazione.pdf: pagina 7

Assessment for Firsteck Bio

Fully on target (coagulation POCT / ACT). WARNING: this is an already AWARDED outcome (2022-2028) to Instrumentation Laboratory/Werfen, so it is not an open opportunity. Strategic value: an excellent benchmark of price and configuration (€ 5,11/ACT test, 1.800 tests/year, fee € 1.200/instrument/year, Hemochron Signature Elite instrument) to reuse for sizing bids on similar ACT tenders and to understand the positioning of competitor Werfen.